Gilead Rival Agrees Not To Sell Generic HIV Drug For Now
By Adam Lidgett · September 2, 2025, 4:05 PM EDT
A Gilead Sciences Inc. competitor has agreed not to sell a generic version of Gilead's human immunodeficiency virus treatment Biktarvy until a trio of patents expire, according to a proposal by...
To view the full article, register now.